tert-Butyl 2-(3-hydroxyazetidin-3-yl)piperidine-1-carboxylate

Catalog No. :
ACGVDN861
CAS No. :
934666-06-5
Molecular Formula :
C13H24N2O3
Molecular Weight :
256.35

IUPAC Name:tert-butyl 2-(3-hydroxyazetidin-3-yl)piperidine-1-carboxylate

tert-Butyl 2-(3-hydroxyazetidin-3-yl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$210.00Login to see priceIn stockIn stock
250mg97%$281.00Login to see priceIn stockIn stock
500mg97%$466.00Login to see priceIn stockInquiry
1g97%$699.00Login to see priceIn stockIn stock
5g97%$2299.00Login to see priceIn stockInquiry
10g97%$3558.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(3-hydroxyazetidin-3-yl)piperidine-1-carboxylate
IUPAC Nametert-butyl 2-(3-hydroxyazetidin-3-yl)piperidine-1-carboxylate
MDL No.MFCD19439669
Molecular FormulaC13H24N2O3
Molecular Weight256.35
SMILESO=C(N1C(C2(O)CNC2)CCCC1)OC(C)(C)C
InChI KeyDBXFIYLGJDPVHA-UHFFFAOYSA-N
Synonym1-Piperidinecarboxylic acid, 2-(3-hydroxy-3-azetidinyl)-, 1,1-diMethylethyl ester;2-(3-Hydroxyazetidin-3-yl)piperidine-1-carboxylic acid tert-butyl ester;3-(1-Boc-2-piperidinyl)-3-azetidinol
CAS No.934666-06-5

Synthetic Route by SureRoute

1. ACGVDN861 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGVDN861 route product structure diagram
    ACGVDN861934666-06-5 In Stock
Inquiry

2. ACGVDN861 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACGVDN861 route product structure diagram
    ACGVDN861934666-06-5 In Stock
Inquiry

Comments (0)